A Case Control Study Of Hypertension In The Setting Of Poverty, Overcrowding And Infection.
Funder
National Health and Medical Research Council
Funding Amount
$603,331.00
Summary
It is unclear why chronic diseases are emerging in regions of significant disadvantage, i.e. where people are not overweight, are physically active and relatively young. We aim to identify factors responsible for the development of high blood pressure in a region where there is overcrowding, poverty, and infection. Low cost strategies to modify risk and educate the community can then be developed to prevent the emergence of these diseases.
My work focuses on the prevention of vascular disease. A major aim of mine is to improve outcome after stroke. We can test this by assessing whether individualised management plans provided to people with stroke will improve risk factors. Proper risk factor management reduces the risk of stroke recurrence. I also aim to reduce the burden of vascular disease in disadvantaged settings by finding out what risk factors are important in the development of these diseases in people living in poverty.
I am an epidemiologist investigating: 1) the frequency, pathogenesis, risk factors and impacts of common age-related eye disease, particularly focused on the four leading causes of blindness: age-related macular degeneration, cataract, glaucoma and diabetic retinopathy; 2) the potential for screening and clinical diagnostic value of retinal imaging and retinal vascular signs as predictors of major systemic conditions such as hypertension, diabetes and cardiovascular disease.
Cancer Epidemiology In High-risk Populations And Complex Cancers
Funder
National Health and Medical Research Council
Funding Amount
$451,716.00
Summary
My research program aims to better understand the causes of cancer and factors that influence outcomes after cancer diagnosis. It employs classical and innovative cancer epidemiology and includes large-scale studies of cancer incidence, survival and risk factors in people with immune dysfunction. It also includes studies of lymphoid malignancies and ‘cancer of unknown primary’ origin. The research program aims to build an evidence base for interventions that will reduce the burden of cancer nati ....My research program aims to better understand the causes of cancer and factors that influence outcomes after cancer diagnosis. It employs classical and innovative cancer epidemiology and includes large-scale studies of cancer incidence, survival and risk factors in people with immune dysfunction. It also includes studies of lymphoid malignancies and ‘cancer of unknown primary’ origin. The research program aims to build an evidence base for interventions that will reduce the burden of cancer nationally and internationally.Read moreRead less
Better Data To Inform Interventions To Reduce The Risk Of Stillbirth In Australia
Funder
National Health and Medical Research Council
Funding Amount
$75,830.00
Summary
Stillbirth is a devastating experience for parents and families. Paucity of high quality data on causes and contributing factors is a major barrier to the development of research priorities and interventions to prevent stillbirths and improve the quality of care. This research will be a connected body of work that aims to better describe the epidemiology of stillbirth in Australia, contribute to the classification of stillbirths and determine the needs of parents in relation to autopsy consent.
Understanding Causes Of The Rising Incidence Of Thyroid Cancer – What Can Mutations In The BRAF Oncogene Tell Us About Causes And Diagnostic Pathways For Thyroid Cancer?
Funder
National Health and Medical Research Council
Funding Amount
$610,222.00
Summary
The occurrence of thyroid cancer has increased rapidly over the last 25 years but the cause is unknown. The increase may reflect ‘over-diagnosis’ of less harmful cancers or greater exposure to causes of this cancer. Evidence suggests that a gene mutation (BRAF) in thyroid cancers is important in understanding the drivers of the increase. This study will examine the increase in thyroid cancer by investigating causes and diagnostic pathways considering the presence or absence of BRAF mutations.